Answers are grounded in this paper and cite their sources.
just as effective as intravenous prostacyclin in removing the reversible component of pulmonary hypertension in our patients, we regard the use of long term intravenous prostacyclin infusion3 as unnecessary, complicated, dangerous, expensive, and certainly of unproved benefit compared with oral vasodilator therapy.
No takes yet. Share an insight, caveat, or question.
G K Crompton (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: